Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
63,223,223
-
Number of holders
-
117
-
Total 13F shares, excl. options
-
38,823,239
-
Shares change
-
+327,524
-
Total reported value, excl. options
-
$260,292,696
-
Value change
-
+$3,224,804
-
Number of buys
-
55
-
Number of sells
-
56
-
Price
-
$6.71
Institutional Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q3 2025
As of 30 Sep 2025 TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) had 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 38,823,239 shares of stock of the company.
Largest 10 holders included ARMISTICE CAPITAL, LLC, BlackRock, Inc., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, VANGUARD GROUP INC, GAGNON SECURITIES LLC, MILLENNIUM MANAGEMENT LLC, CIBC Private Wealth Group LLC, JPMORGAN CHASE & CO, First Eagle Investment Management, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 117 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.